2024    2023    2022    2021    2020    2019    2018    2017    2016   

2020

Articles

101 - 

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas

Ajay K Gopal, Ronald Levy, Roch Houot, Sandip P Patel, Leslie Popplewell et al.

Clinical Cancer Research, 2020, 26 (11), pp.2524-2534.

DOI : https://doi.org/10.1158/1078-0432.CCR-19-2973

Pubmed : 32144134

 

102 - 

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning

Åsa K Hedman, Camilla Hage, Anil Sharma, Mary Julia Brosnan, Leonard Buckbinder et al.

Heart, 2020, 106 (5), pp.342-349.

DOI : https://doi.org/10.1136/heartjnl-2019-315481

Pubmed : 31911501

 

103 - 

Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? Yes

Anne Kerbrat, Gilles Edan

Revue Neurologique, 2020, 176 (6), pp.487-489. ⟨hal-02885973v2⟩

DOI : https://doi.org/10.1016/j.neurol.2020.03.006

Pubmed : 32359947

 

104 - 

Breathing Rate Estimation Using Kalman Smoother with Electrocardiogram and Photoplethysmogram

S. Khreis, D. Ge, Hala Abdul Rahman, G. Carrault

IEEE Transactions on Biomedical Engineering, 2020, 67 (3), pp.893-904.

DOI : https://doi.org/10.1109/TBME.2019.2923448

Pubmed : 31217092

 

105 - 

Association of estimated plasma volume status with hemodynamic and echocardiographic parameters

Masatake Kobayashi, Olivier Huttin, Erwan Donal, Kévin Duarte, Arnaud Hubert et al.

Clinical Research in Cardiology, 2020, 109 (8), pp.1060-1069.

DOI : https://doi.org/10.1007/s00392-020-01599-9

Pubmed : 32006155

 

106 - 

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

Aviv Ladanie, Andreas M Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal et al.

JAMA Network Open, 2020, 3 (11), pp.e2024406.

DOI : https://doi.org/10.1001/jamanetworkopen.2020.24406

Pubmed : 33170262

 

107 - 

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Loriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, David Laharie, Xavier Roblin et al.

Digestive and Liver Disease, 2020, 52 (3), pp.268-273.

DOI : https://doi.org/10.1016/j.dld.2019.10.003

Pubmed : 31732444

 

108 - 

Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC

Louise Laisne, Bénédicte Neven, J-H Dalle, Claire Galambrun, Maxime Esvan et al.

Pediatric Blood and Cancer, 2020, 67 (9), pp.e28233.

DOI : https://doi.org/10.1002/pbc.28233

Pubmed : 32614145

 

109 - 

TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study

Sébastien Lalanne, Caroline Jezequel, Camille Tron, Marie-Clémence Verdier, Marion Mercerolle et al.

Therapeutic Drug Monitoring, 2020, 42 (2), pp.163-164.

DOI : https://doi.org/10.1097/FTD.0000000000000718

Pubmed : 32195986

 

110 - 

Near infrared spectroscopy would be assessed for lower extremity peripheral artery disease diagnosis in patients with normal ankle-brachial index at rest

Damien Lanéelle, Marie Charasson, Chadi Mauger, Guillaume Mahé

Journal of Vascular Surgery, 2020, 71 (3), pp.1071-1072.

DOI : https://doi.org/10.1016/j.jvs.2019.09.066

Pubmed : 32089204